Study of Urokinase Plasminogen Activator in Breast Cancer
Author Information
Author(s): S Kennedy, MJ Duffy, C Duggan, C Barnes, R Rafferty, MD Kramer
Primary Institution: Royal Victoria Eye and Ear Hospital, Dublin, Ireland
Hypothesis
The study aims to semiquantitate levels of urokinase plasminogen activator (uPA) and its receptor (uPAR) in invasive breast cancers using immunocytochemistry.
Conclusion
Both uPA and its receptor are predominantly present in stromal cells in invasive breast carcinomas, suggesting that these cells may collaborate with malignant cells to mediate metastasis.
Supporting Evidence
- uPA was detected in 94.4% of cases in stromal cells, while malignant cell staining was found in 63.6% of samples.
- uPAR was localized principally to stromal cells surrounding invasive breast cancer, rarely detected in cancer cells.
- Significant correlation was found between uPA and uPAR levels in both malignant and stromal cells.
Takeaway
This study looked at a special protein involved in cancer spread and found it mostly in the support cells around the cancer, not in the cancer cells themselves.
Methodology
Breast tumor tissue was obtained and stained for uPA and uPAR using specific monoclonal antibodies, with immunoreactivity evaluated semiquantitatively.
Limitations
The study did not find significant relationships between uPA/uPAR levels and established prognostic markers like tumor size or nodal status.
Statistical Information
P-Value
0.0001
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website